SARM1 and neuropathy: Sarm1 deletion has shown to have significant protective effects on axon loss in animal models of traumatic brain injury, metabolic neuropathy and several models of chemotherapy induced neuropathy (Geisler et al., 2016, 2019a; Henninger et al., 2016; Turkiew et al., 2017; Cheng et al., 2019; Marion et al., 2019; Bosanac et al., 2021; Gould et al., 2021b).